RRAS2 and gastric cancer: Finally, 11 candidate TAAs were identified, and autoantibodies against these 11 TAAs, including INPP5A, F8, NRAS, MFGE8, PTP4A1, RRAS2, RGS4, RHOG, SRARP, RAC1, and TMEM243 were evaluated as potential markers in GC.